Daily Stock List
Uranerz Energy Corp. (URZ)
Streetwise Reports and Greenbackers reported recently on Uranerz Energy Corp. (URZ), SmarTrend Newsletters, Top Stock Analysts, and The Street did earlier, and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Uranerz Energy Corp.is a mining company concentrating on near term commercial in-situ recovery (ISR) uranium production. The Company isconstructing their first ISR mine in the Powder River Basin of Wyoming. This is the Nichols Ranch ISR Uranium Project.The expectation is that the Nichols Ranch ISR Uranium Project will become the first new uranium mine built in Wyoming since 1996.Uranerz Energy is based in Casper, Wyoming.
In-situ recovery (ISR) is a mining process that utilizes a leaching solution to extract uranium from sandstone-hosted uranium deposits. It is the generally accepted extraction technology used in the PowderRiver Basin. The Powder River Basin ofWyoming is an area well known for hosting uranium-mineralized roll frontsthat are amenable to ISR mining techniques.
Uranerz Energy has a processing agreement with Cameco. The Company has also entered into long-term uranium sales contracts for a portion of their planned production with two of the largest nuclear utilities in the U.S., including Exelon.
Uranerz hasseveral advanced-stage projects in the PumpkinButtes Mining District of the central Powder River Basin. The Nichols Ranch ISR Uranium Project has licensingfor a capacity of 2 millionpounds per year of uranium yellowcake. The initial target production rate is 600,000to 800,000 pounds per year, following a ramp up period.Construction of the central processing plant and installation of the environmental monitor and production wells for ISR mining are proceeding, with completion targeted for2013.
In October 2012,Uranerz Energy announced that the Wyoming Department of Environmental Quality issued the Class I Underground Injection Control (deep disposal well) permit for the Company's Nichols Ranch ISR Uranium Project. This deep disposal well authorization is the last permit required to start operations and commercial uranium production at Nichols Ranch. The Companyhas now received all federal and Wyoming State permits for Nichols Ranch mineproduction.
Recently, Uranerz Energy announced that they closed a short-term note financing with a select group of investors in the collective amount of US$6,000,000. The use of the Note financing proceeds will be to fund ongoing construction of the Company's Nichols Ranch ISR Uranium Project.
Uranerz Energy Corp. (URZ), closed at $1.20, down 1.64%, on 160,010 volume with 505 trades. The average volume for the last 60 days is 399,952 and the stock's 52-week low/high is $0.8826/$1.89.
Patient Safety Technologies, Inc. (PSTX)
Real Pennies reported previously on Patient Safety Technologies, Inc. (PSTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Patient Safety Technologies, Inc.via their wholly-owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge® System. This is a solution clinically proven to improve patient safety and reduce healthcare costs. It does so by helping prevent one of the most common errors in surgery, retained surgical sponges. Patient Safety Technologies’ shares trade on the OTC Markets’ OTCQB. The Company is based in Irvine, California.
Patient Safety Technologies purchasedSurgiCount Medical in 2005.They purchased them with the objective of commercially developing the promisingSafety-Sponge™ System into the industry standard for preventing retained sponges. They received Food and Drug Administration(FDA) clearance to market the system in March of 2006.
Currently, Safety-Sponge® System is used in more than 300 government, teaching and community hospitals across the United States. This includes seven of the 2012-2013 US News and World Report Best Hospitals Honor Roll recipients.
The Safety-Sponge® System consists of three components - the SurgiCounter™, Safety-Sponges®, and SurgiCount360™. Collectively, the components help eliminate retained surgical sponges through providing more accurate, real-time counts in the operating room. In addition, they provide auditable, post-operative evidence based outcomes through a complete documentation solution.
In June,Patient Safety Technologies’ subsidiary, SurgiCount Medical, and LHP Hospital Group announced the system wide implementation of the SurgiCount Safety-Sponge® System at LHP facilities. Based in Plano, Texas, LHP is a privately held healthcare leader established to provide essential capital and expertise to not-for-profit hospitals and hospital systems.
Moreover, in June,SurgiCount Medical announced that they signed an agreement with GNYHA Services, Inc. of New York, New York, to provide the SurgiCount Safety-Sponge® System to their health system members.The agreement provides terms under which GNYHA Services members have access to the Safety-Sponge® System for those who choose to implement the solution for their retained sponge prevention strategy.GNYHA Services is a wholly owned, for-profit subsidiary of the Greater New York Hospital Association (GNYHA).
Patient Safety Technologies, Inc. (PSTX), closed Friday’s trading session at $2.07, down 0.48%, on 64,844 volume with 52 trades. The average volume for the last 60 days is 28,589 and the stock's 52-week low/high is $1.10/$2.15.
Nemaska Lithium, Inc. (NMX.V)
BabyBulls reported previously on Nemaska Lithium, Inc. (NMX.V), and we highlight the Company, here at the QualityStocks Daily Newsletter.
List on the TSX Venture Exchange, Nemaska Lithium, Inc. is an exploration and development enterprise. The Company’s goal is to become a lithium hydroxide/carbonate producer based in the Province of Quebec.Nemaska is focusing on the development of their 100 percent owned Whabouchi lithium deposit. The Company has the Whabouchi as well as their Sirmac lithium deposits in Quebec. Nemaska has lithium/berylium properties in the James Bay region of Quebec.Moreover,Nemaska Lithium is an important shareholder of Monarques Resources, Inc. (MQR.V).
The Whabouchi lithium deposit is closetothe Cree community of Nemaska and the Nemiscau airport. The Company's Whabouchi deposit is the second richest deposit in the world.The Whabouchi Property consists of one block totaling 33 claims covering an area of 1,761.9 ha. The claims are 100 percent-owned by Nemaska Lithium.The Sirmac Property consists of 15 claims covering a total area of 645 ha.
Nemaska Lithium has filed patent applications for their proprietary method to produce lithium hydroxide and lithium carbonate.The Company’s intention is to construct a Phase I lithium hydroxide plant utilizing their proprietary chemical transformation process.Their lithium hydroxide/carbonate processing plant will be inSalaberry-de-Valleyfield, Quebec.The design of the plant has been with the flexibility to produce 27,000 tonnes of lithium hydroxide and 4,000 tonnes of lithium carbonate should the market demand for hydroxide outpace lithium carbonate.
In conjunction, Nemaska is developing one of the richest spodumene lithium hard rock depositsglobally. This is both in volume and grade. Spodumene concentrate produced at the Company’s Whabouchi mine and from other worldwide sources will be shipped to their lithium hydroxide/carbonate processing plant in Salaberry-de-Valleyfield. This plant will transform spodumene concentrate into high purity lithium hydroxide and lithium carbonate for the emergent lithium battery market.
Recently, Nemaska Lithium announced that the Environmental Social Economic Impact Assessment reports for their Whabouchi project werefiled with the Canadian Environmental Assessment Agency and the Développement durable, Environnement, Faune et Parcs Québec. Nemaska is expecting feedback from both organizations over the next months. The Company will provide an appropriate response to expedite permitting. The Company additionally announced that they filed and received a permit for a 25,000 tonne bulk sample to be taken from the Whabouchi mine site.
Nemaska Lithium, Inc. (NMX.V), closed Friday’s trading session at $0.17, up 9.68%, on 11,200 volume. The stock's 52-week low/high is $0.13/$0.65.
Canada Lithium Corp. (CLQ.TO)
Stockhouse and Streetwise Reports reported previously on Canada Lithium Corp. (CLQ.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, Canada Lithium Corp.is a "clean-tech" mine developer. Theyhold a 100 percent interest in the Québec Lithium Project near Val d'Or, Quebec. This project has completed construction; it is in the commissioning phase of an open-pit mine and on-site processing plant. Lithium carbonate is used in lithium-ion batteries that power consumer electronics. Canada Lithium also lists on the OTCQX International under the trading symbol “CLQMF”. The Company has their headquarters in Toronto, Ontario.
The Quebec Lithium Project is operated under Quebec Lithium, Inc. The Project isin the northeast corner of La Corne Township, approximately 38 km southeast of Amos, 15 km west of Barraute, and 60 km north of Val d'Or.Construction of the mine and process plant commenced in August of 2011.It completed early this year. Commissioning is currently in the latter stages.
The Quebec Lithium Project consists of 12 contiguous claims covering 404.69 hectares.The lithium carbonate processing facility on site will treat crushed pegmatite ores. This is to produce an intermediate 6.5 percent spodumene product that will be upgraded, on site, to produce lithium carbonate.
Last week, Canada Lithium announced that they produced theirfirst run of 99.1 percent lithium carbonate from their processing plant near Val d'Or, Québec. This material is now being upgraded to 99.5 percent battery-grade material with the commissioning of the solvent extraction and bicarbonate circuits.
Production from the mine will gradually be increased to build up ore stockpiles at the processing plant. The ramp-up to annual design capacity of 20,000 tonnes of lithium carbonate is still scheduled to be completed in Q1, 2014.A five-year off-take agreement for a minimum of 12,000 tonnes per year was signed recently with Tewoo-ERDC, one of China's largest commodities traders. A second off-take for up to 5,000 tonnes per year was also signed recently with Marubeni Corp., a major Japanese commodities trading company.
Canada Lithium Corp. (CLQ.TO), closed Friday’s trading session at $0.56, down 1.76%, on 271,738 volume. The stock's 52-week low/high is $0.47/$0.96.
Hancock Fabrics, Inc. (HKFI)
SmarTrend Newsletters reported recently on Hancock Fabrics, Inc. (HKFI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Founded in 1957, Hancock Fabrics, Inc. is a specialty retailer whose shares trade on the OTCQB. The Company’s dedication is to serving creative enthusiasts with a complete selection of fashion and home decorating textiles, sewing accessories, needlecraft supplies, as well as sewing machines.Hancock Fabrics operates stores mainly in strip shopping centers. The Company has their corporate headquarters in Baldwyn, Mississippi.
Currently, Hancock Fabrics operates 261 retail stores in 37 states. The Company also has an Internet store at www.hancockfabrics.com.Their stores offer apparel fabrics; home decorating products, including drapery and upholstery fabrics, and home accent pieces. They also offer quilting materials; and notions consisting of sewing aids and accessories, such as zippers, buttons, threads, sewing machines, and patterns. Moreover, they offer seasonal and current fashion merchandise.
In June,Hancock Fabrics announced their financial results for the Company’s first quarter ended April 27, 2013.Net sales for the quarter were $63.7 million. This is in comparison to $63.9 million for the first quarter of the year prior. Gross profit for the quarter increased by 470 basis points to 45.5 percent, in comparison to 40.8 percent in the first quarter of 2012. This represents an improvement of $2.9 million.
Operating income increased 209 percent to $1.3 million, in comparison to an operating loss of $1.2 million in the first quarter the prior year. This represents an increase of $2.5 million; it also represents an increase of 390 basis points as a percentage of sales. Thenon-GAAP measureEBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) increased $2.3 million to $2.5 million in this quarter. This isversus $207,000 for the first quarter of 2012.
The Company’s net loss was $0.5 million, or $0.02 per basic share, in the first quarter of fiscal 2013. This represents an improvement of $1.9 million in comparison to a net loss of $2.4 million, or $0.12 per basic share in the first quarter of fiscal 2012.
Hancock Fabrics, Inc. (HKFI), closed Friday’s session at $1.10, even for the day, on 1,800 volume with 5 trades. The average volume for the last 60 days is 15,869 and the stock's 52-week low/high is $0.305/$1.12.
XcelMobility, Inc. (XCLL)
PennyStocks24, Penny Stock Rumble, Pennybuster, and Greenbackers reported recently on XcelMobility, Inc. (XCLL), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Based in Redwood City, California, XcelMobility, Inc. is a foremost developer of mobile internet products and services. The Company isprecisely focusing on China's growing mobile market.XcelMobility has developed an online product website, www.mach5.cn, where resellers, developers and consumers, can access the Company’scollection of Mach5 products.Mach 5 is the application that enables users to have a faster, secure desktop experience on their mobile devices.XcelMobility lists on the OTC Markets’ OTCQB.
XcelMobility has deep relationships with China's leading mobile operators. The Company hasthe ability to incorporate today’s most interactive and technologically advanced social and gaming applications to their family of mobile internet products and services.XcelMobility executes their business model by way of numerous subsidiaries located in Hong Kong and Shenzhen, China.
Their Mach5 products include the Mach5 Accelerator; this is Xcel's flagship product, whichconsiderably accelerates internet access. The Company’s products also include the Mach5 LBS; this is their newest technology, which allows developers and businesses to easily add advanced location capabilities to their mobile applications.XcelMobility has become the leader in providing location-based services for China's mobile marketwith the introduction of their Mach5 LBS.
The Company utilizes patented software and algorithms to further compress voice and data transmissions sent over cellular networks. Software installed on the mobile device -Mach 5 software either through a download or embedded by cellular manufacturers - is sent to the closest bank of XcelMobility servers, strategically located throughout China, Japan and Hong Kong. There it further compresses data and sends it back and forth between one’s phone and the website or server they are accessing.
Recently,XcelMobility announced that they acquired the video encoding and compression group of Shenzhen Jifu Communication Technology Co., Ltd. Shenzhen Jifu is a professional manufacturer. Their specialities are video surveillance systems, software platforms, as well as fiber optic solutions.
With thisagreement, XcelMobility will issue atotal of 30,000,000 shares of the Company's common stock to the Shenzhen Jifu Stakeholders. The shares will be released after the Company has reviewed Shenzhen Jifu’s audited financial statements for the year ended December 31, 2013 and Shenzhen Jifu has achieved revenues of at least $4,000,000.
XcelMobility, Inc. (XCLL), closed Friday’s trading session at $0.065, even for the day, on 69,800 volume with 11 trades. The average volume for the last 60 days is 227,269 and the stock's 52-week low/high is $0.035/$0.33.
Spire Corp. (SPIR)
Money Morning and SmarTrend Newsletters reported earlier on Spire Corp. (SPIR), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Spire Corp.is a global solar company that lists on the OTC Markets’ OTCQB. The Company provides capital equipment and turnkey production lines to manufacture photovoltaic (PV) modules. The Company additionally providesengineering, procurement and construction (EPC) integration services for solar systems and biomedical processing services. Spire has their corporate headquarters in Bedford, Massachusetts.
Spire has developed, manufactured, and marketed highly engineered products and services for a broad spectrum of commercial markets since 1969. These include energy manufacturing equipment, biomedical devices and optoelectronic components.Spire alsohas more than 20 years of experience in III-V epitaxial wafer growth and device fabrication services.
In the photovoltaic solar area, Spire develops, manufactures, and markets specialized equipment for the production of terrestrial PV modules from solar cells. They also providePV systems for grid connected applications in the commercial markets. The Company’s equipment has been installed in approximately 200 factories in 50 countries.
Their flagship product is their Sun Simulator. This product tests module performance. Their other product offerings include turnkey module lines and to a lesser extent other individual equipment. Spire also offers other services including training and assistance with module certification. Additionally, they provide turnkey services to their customers to backward integrate to solar cell manufacturing. From time to time, they supply materials such as solar cells to certain customers.
In the biomedical area, Spire provides value-added surface treatments to manufacturers of orthopedic and other medical devices that enhance the durability, antimicrobial characteristics or other material characteristics of their products. In addition, the Company performs sponsored research programs into practical applications of advanced biomedical and biophotonic technologies.
Spire solar manufacturing equipment is used by 90 percent of the world's solar module and cell producers. In regards to Solar Production Lines, the Company provides turnkey solar factories to businesses around the world.Moreover, Spire works with material and module suppliers to help in obtaining materials and modules for solar manufacturing.
The Company has created valuable intellectual property (IP) assets. These are represented by over 70 patents. Spire has comprehensive R&D labs and manufacturing facilities.Spire R&D develops unique products in the biomaterials, medical implants, biophotonics instrumentation and life sciences, defense electronics and homeland security, alternative energy, and telecommunications fields.
Spire Corp. (SPIR), closed Friday’s trading at $0.40, up 14.29%, on 20,469 volume with 8 trades. The average volume for the last 60 days is 4,111 and the stock's 52-week low/high is $0.11/$0.9901.
Falcon Oil & Gas Ltd. (FOLGF)
PennyInvest, HotOTC, MadPennyStocks, BullRally, StockRich, StockEgg, PennyStockVille, and CoolPennyStocks reported previously on Falcon Oil & Gas Ltd. (FOLGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Falcon Oil & Gas Ltd.engages in the acquisition, exploration, development, and production of oil and gas properties mainly in Australia, South Africa, and Hungary. The Company is an internationalenergy company focusing on acquiring, exploring and developing large acreage positions of unconventional and conventional oil and gas resources.Falcon holds nearly 15 million acres in three major exploration projects. The Company is based in Dublin, Ireland; their shares trade on the OTC Pink Current Information.
Falcon Oil & Gas Australia Ltd. is the majority owned subsidiary of Falcon Oil & Gas Ltd. Falcon Australia is an oil and gas company engaged in the exploration and development of world class conventional and unconventional resources in the Beetaloo Basin, Northern Territory, Australia.In the Beetaloo Basin, Falcon Australia holds 100 percent interest in more than seven million acres in Exploration Permits 98, 99, 76, and 117 covering the greater part of the Basin.
In theKaroo Basin, South Africa,Falcon holds a Technical Cooperation Permit (TCP) covering an area of approximately 7.5 million acres (approximately 30,327 km2) onshore Karoo Basin. In theMakó Trough, Hungary, Falcon’s subsidiary, TXM, holds the 35-year Makó Production Licence covering an area of approximately 245,775 acres (approximately 1,000 km2) situated in the Makó Trough, part of the greater Pannonian Basin of central Europe.
In January 2013, FalconOil & Gas agreed to a three-well drilling exploration program with NIS, owned 56 per cent by the Gazprom Group. This program is to target the Algyö Play. NIS made a cash payment of US$1.5 million to Falcon and agreed to drill three exploration wells by July 2014.
In June,Falcon Oil & Gas announced that further to their announcementon May 23, 2013, the firstofthreeexploration wells“Kútvölgy-1”,to evaluate thegaspotential ofthe Algyö Formation at a depthofapproximately3,000min the Mako Trough, underwent spudding on June 11, 2013.The Algyö is a relatively shallow play between 2,300m and 3,500m.
Last week,the Company announced that HessAustralia (Beetaloo) Pty Ltd. did notelect to commit to drilling the fivewells required to earn their interest in the Beetaloo permits by the agreed deadline of 10pm Friday, June 28, 2013.In accordance with theParticipation Agreement dated April 28, 2011,as amended on August 2, 2012,whichgrantedHess the first extension, failure to electon time means that Hess forfeits their right to earn 62.5 percent in three of the Beetaloo permits.
Falcon Oil & Gas Ltd. (FOLGF), closed Friday’ssession at $0.215, down 2.27%, on 192,330 volume with 10 trades. The average volume for the last 60 days is 236,328 and the stock's 52-week low/high is $0.128/$0.316.
Solar Wind Energy Tower, Inc. (SWET)
The QualityStocks Daily Newsletter would like to spotlight Solar Wind Energy Tower, Inc. (SWET). Today, Solar Wind Energy Tower, Inc. closed trading at $0.0245, up 8.89%, on 569,293 volume with 25 trades. The stock’s average daily volume over the past 60 days is 465,410, and its 52-week low/high is $0.01/$0.08.
Solar Wind Energy Tower, Inc. (SWET) is focused on commercializing a number of proven, validated technologies and construction systems into a single large Solar Wind Downdraft Tower structure that produces abundant, inexpensive electricity. The company's core objective is to become a leading provider of clean, efficient energy at a reasonable cost, while continuing to generate innovative technological solutions for tomorrow's electrical power needs.
The company's cutting-edge energy solution generates clean energy by harnessing the natural power of a downdraft created within the confines of a Solar Wind Downdraft Tower structure. Using benevolent, non-toxic natural elements, the solar/wind hybrid technology is capable of being operated with virtually no carbon footprint, fuel consumption, or waste production. To view a demonstration of the tower, visit http://dtg.fm/4Gp7.
The business plan employed by Solar Wind Energy includes partnering with various entities, such as utilities, sovereign nations, and independent power sources, to bring this solution to the market as rapidly as possible. The company's role would consist of facilitating the Tower's development with its expertise and intellectual property. Revenue streams include development fees, licensing fees, and royalties on power sales from each project and/or ownership interests.
Solar Wind Energy has assembled a team of experienced business professionals, as well as engineering and scientific consultants, with the proven ability to bring new ideas to market. The company has also filed and been issued patents that protect its revolutionary technology and leading position in the continual global pursuit to meet rising demand for energy. Disclaimer
Solar Wind Energy Tower, Inc. Company Blog
Solar Wind Energy Tower, Inc. News:
Solar Wind Energy Tower, Inc. Statement From CEO Ronald W. Pickett
Solar Wind Energy Tower, Inc. CEO Featured in Exclusive QualityStocks Interview
Solar Wind Energy Tower, Inc. Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.25, up 7.53%, on 142,495 volume with 36 trades. The stock’s average daily volume over the past 60 days is 96,684, and its 52-week low/high is $0.161/$0.41.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Present Data From Its Parkinson's Disease Program at Society for Neuroscience Annual Meeting
International Stem Cell Subsidiary Lifeline Skin Care Expands Asian Distribution
International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease Program
GRILLiT, Inc. (GRLT)
The QualityStocks Daily Newsletter would like to spotlight GRILLiT, Inc. (GRLT). Today, GRILLiT, Inc. closed trading at $0.50, up 38.89%, on 400 volume with 1 trade. The stock’s average daily volume over the past 60 days is 6,601, and its 52-week low/high is $0.11/$1.50.
GRILLiT, Inc. (GRLT) was founded on the concept of delivering a fast-casual dining experience with fresh, nutritious home-style cooking. Leveraging more than four decades of experience in the food industry, the founders of GRILLiT established this unique business model to satisfy the ever-increasing demand for delicious and healthy food while providing the perfect ambiance for guest to relax and enjoy great cuisine.
The company sources its ingredients from local and domestic farmers to ensure crisp, fresh produce and grain-fed Angus beef. The cooking techniques and low-sodium recipes employed result in uniquely healthy and delectable meal choices. Using the best possible ingredients, GRILLiT chefs have created an inspiring flavor profile using fresh herbs spices and all-natural marinades.
The management team executing GRILLiT’s business strategy has been carefully assembled to achieve rapid growth and profitability. One of the most recent additions, Rob Elliott, brings more than 25 years of experience in restaurant franchise system development, marketing, branding, and operations. Previously serving as Vice President of Marketing for Little Caesars Pizza, he was instrumental in expanding the number of store locations from 150 to 5,000.
GRILLiT is focused on expanding throughout the southeastern United States and offers nationwide franchising opportunities. Current locations operate in high-traffic shopping plazas and offer American, Asian Fusion, and Latin American food styles. The company’s growth strategy is based on a five-year plan to roll out a total of 79 stores in nine States: Florida, Kentucky, Ohio, New Jersey, New Hampshire, North Carolina, Tennessee, Georgia, and Pennsylvania. Disclaimer
GRILLiT, Inc. Company Blog
GRILLiT, Inc. News:
GRILLiT® Brings Top Franchise Branding/PR Firm Aboard
GRILLiT®, Inc. Announces Common Stock Dividend to its Shareholders
GRILLiT®, Inc. Elects Accompplished Restaurant Veteran As Chairman Of Its Board Of Directors
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.07, up 7.69%, on 461,881 volume with 169 trades. The stock’s average daily volume over the past 60 days is 451,381, and its 52-week low/high is $0.06/$0.2608.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
StreamTrack and One World Media Group Announce Agreement With Monaco Media International
StreamTrack Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
StreamTrack Announces Operating Results for Second Quarter Fiscal 2013
The market for Internet radio is rapidly growing as consumers trend toward streaming music via more convenient and mobile Internet-connected devices such as smart phones, tablets, automobiles, and more. This budding market provides a wide opportunity for creative and cost-effective marketing strategies for advertisers willing to make the shift from terrestrial radio campaigns to streaming stations.
In 2013 the number of U.S. Internet radio listeners will increase by 11.1 percent to 147.3 million and continue to grow through the next several years, according to research from eMarkter. The majority of capital that keeps the Internet radio afloat comes primarily from advertising dollars – subscription fees contribute a smaller portion.
Small-cap digital media and technology services company, StreamTrack, has taken notice of the shift toward Internet radio and has developed a suite of tools designed to provide advertisers with cost-effective means to reach their target audience over this medium. The company offers several solutions specifically for agencies and advertisers, publishers and broadcasters, mobile providers, and developers and partners:
• Video – one of the fasted growing online advertising formats. StreamTrack’s RadioLoyalty™ platform utilizes patent pending in-stream video technology transforming audio impressions into video impressions.
• Display advertising – this medium has evolved from “banner ads” to a wider scope of display ad formats including rich media and video. With RadioLoyalty™’s UniversalPlayer, advertisers know exactly how their campaign will look across all radio stations.
• Mobile marketing – has come onto the scene with rapid growth, increasing by 39 percent compared to 2011. With RadioLoyalty™, StreamTrack clients can reach users and consumers throughout the day. With mobile inventory growing daily, both buyers and sellers are treating online video and mobile video as one and the same.
eMarketer estimates that Internet radio ad spending in the U.S. will top $970 million in 2013 and grow to $1.31 billion by 2016. RadioLoyalty provides audio, video streaming, and advertising services to more than 1,500 Internet and terrestrial radio stations, positioning StreamTrack to take a chunk of this market share and capitalize on the consumer shift toward Internet radio on a global scale.
StreamTrack recently formed an alliance with PPTV, China Mobile Entertainment Holdings, LTD, and One World Media Group as part of an historic alliance to bring Internet radio to Asia including China.
For more information, visit www.StreamTrack.com
Raptor Resources, a U.S. based mineral resource acquisition, exploration, and development company currently focused on active projects in Zimbabwe Africa, depends upon a number of partnerships and subsidiaries to efficiently handle distant projects. These companies are experienced and familiar with both the mining industry and the region.
One of Raptor’s key relationships is with their minority-owned partner, WGB Kinsey & Company, a 4th generation mining and construction company in Zimbabwe since 1955. Kinsey is one of Zimbabwe’s most experienced mining and construction companies, with both open pit and open cast mining experience ranging from chrome to platinum to gold. They own an impressive fleet of articulated dump trucks, front-end wheeled loaders, excavators, dozers, and graders. But Kinsey’s long-established reputation goes well beyond equipment.
Over the years, Kinsey has developed a unique system that helps them efficiently monitor resources and better manage on-site activities, in addition to strengthening cost control, safety, and environmental oversight. They have long-standing connections with major equipment suppliers, such as Caterpillar, and have the ability to continually upgrade their fleet. In addition, they hold a large store of other supplies and necessities that ensure continuous operation. They know how to keep projects running smoothly and on time.
Kinsey is managing all operations of Raptor’s Dodge mining project, working closely with Raptor’s subsidiary Mabwe Minerals, another key Raptor relationship. The Dodge project is a very important and active development for Raptor, representing what is now being called a world class deposit of barite (BaSO4), an important mineral used throughout the world in the oil and gas industry. The company already has a major buyer for barite output, looking for a total of 3 million metric tons of barite over the next 13.5 years, valued at hundreds of millions of dollars.
For more information on Raptor Resources, visit www.raptorresourcesholdings.com
Applied DNA Sciences, a provider of DNA-based anti-counterfeiting technology, anti-theft, and product authentication solutions, reports that its ongoing expansion efforts have resulted in a 72 percent increase in its staff of scientific, quality, operational, and other employees since January, which brings its total employee count to 48.
“The addition of top-notch people and an improved facility are two keys to handling growth,” Dr. James A. Hayward, CEO and president of Applied DNA Sciences stated in the press release. “Our grow-the-company initiative will keep us steadily on the edge of science and innovation, something our customers have come to expect from us. We are prepared to deliver.”
The company’s expansion efforts are complementary to its worldwide growth initiatives, which include a broader range of product offerings and a growing sales pipeline.
To further support the expansion, the company is currently moving into a new, 30,000-square foot facility that features significantly larger and differentiated laboratory space, improved security, new staging, shipping and fulfillment centers, and an expanded front office.
AppliedDNA said it is also seeing an increase in the number of contracts with suppliers of military electronics (currently a total of 16), as well as an increase in calls for anti-theft assets. As part of its broader “Technology Roadmap,” Dr. Hayward said the company envisions a faster and higher-volume SigNature DNA marking platform, highly optimized rapid read, new breakthroughs in textile marking and authentication, and other technological advances.
“We will remain light on our feet and able to serve customers quickly and with precision,” he concluded. “Our new infrastructure is built to empower that philosophy.”
For more information, visit www.adnas.com
Generex Biotechnology Corporation has announced the details of an upcoming conference call it will host featuring members of the Antigen Express, Inc. Scientific Advisory Board. The call will take place Wednesday, Aug. 14 at 10 a.m. EDT. Call-in information will be announced prior to the conference call.
Included among members of the Antigen Express Scientific Advisory Board who will be acting as panelists on the call will be: Dr. Gary H. Lyman, M.D., M.P.H., FACP, FRCP (Edin), FASCO; Dr. Gabriel N. Hortobagyi, M.D., FACP; Dr. Ian Krop, M.D., Ph.D.; Dr. Keith L. Knutson, Ph.D.; Dr. James J. Mule, Ph.D.; Dr. Hope S. Rugo, M.D.; Dr. Samuel Jacobs, M.D.; and Dr. Elizabeth Mittendorf, M.D., Ph.D.
The call will cover various topics, including: highlights from the company’s June 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO); an update on the ongoing Phase II clinical trial of the AE37 breast cancer vaccine; the current state of breast cancer treatment and treatment trends; treatment options for patients who express low levels of HER2; a review of antibodies and vaccines in immunotherapy, and the importance of CD4+ T cell activation by li-Key; biomarkers and personalized medicine in cancer care and opportunities for the li-Key platform; treatment options for triple-negative breast cancer; and an update from the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the potential for AE37.
Generex is a biotechnology company focused on researching, developing, and commercializing drug delivery systems and technologies. The company has developed a proprietary platform technology for delivering drugs into the human body through the oral cavity (with no deposit in the lungs). Using the company’s RapidMist device, its proprietary liquid formulations allow drugs that are typically administered by injection to be absorbed into the body by the inner mouth lining.
For more information about Generex, visit www.generex.com
Today's Top 3
Pumps and Dumps
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Requests Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer with ADXS-HPV
- Cardium Therapeutics, Inc. (CXM) Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013
- DoMark International, Inc. (DOMK) Positioned for Substantial Growth With Imagic's Revolutionary Product for Smartphone & Gaming Enthusiasts Which Has Finalized Development for Production in Q3
- Frozen Food Gift Group Inc. (FROZ) Announces Partnership To Launch Groundbreaking Ice Machine Sanitation Technology
- GlobalWise Investments, Inc. (GWIV) Enters Into New Channel Sales Partnership With TGI Office Automation
- GNCC Capital, Inc. (GNCP) Completes the Acquisition of the White Hills Gold Properties
- GRILLiT®, Inc. (GRLT) Postpones Record Date for Common Stock Dividend
- International Stem Cell Corp. (ISCO) to Present Data From Its Parkinson's Disease Program at Society for Neuroscience Annual Meeting
- Mabwe Minerals Inc. (MBMI) Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
- Players Network (PNTV) Launches Las Vegas Lifestyle Channel and Social Community
- Rafarma Pharmaceuticals, Inc. (RAFA) Enters $50M Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
- Rainbow Coral Corp. (RBCC) Insurance Companies, Researchers Drive Growth in Personalized Medicine
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
- Solar Wind Energy Tower, Inc. (SWET) CEO Featured in Exclusive QualityStocks Interview
- StreamTrack, Inc. (STTK) RadioLoyalty Announces the Release of Its New UniversalPlayer™
- The Aristocrat Group Corp. (ASCC) Targets Booming Texas Market for Exclusive Beverage Distribution
- The Guitammer Company Inc. (GTMM) ButtKicker Gamer2, Two "Butts" Are Better Than One
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Closing of Private Placement and Corporate Update
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement